Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

By Grant R.   Shorvon S.D.  

Epilepsy Research, Vol. 42, Iss. 2, 2000-12 ,pp. : 89-95

Elsevier

Access to resources Recommend Favorite

Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy

By Malmgren K.   Hedstrom A.   Granqvist R.   Malmgren H.   Ben-Menachem E.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 199-207

Elsevier

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures

By Ben-Menachem E.   Hamberger A.   Hedner T.   Hammond E.J.   Uthman B.M.   Slater J.   Treig T.   Stefan H.   Ramsay R.E.   Wernicke J.F.   Wilder B.J.  

Epilepsy Research, Vol. 20, Iss. 3, 1995-03 ,pp. : 221-227

Elsevier

Access to resources Recommend Favorite

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

By Ben-Menachem E.   Edrich P.   Van Vleymen B.   Sander J.W.A.S.   Schmidt B.  

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 57-64

Elsevier

Access to resources Recommend Favorite